scholarly journals Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors

Nanoscale ◽  
2014 ◽  
Vol 6 (17) ◽  
pp. 10377-10387 ◽  
Author(s):  
Patrick V. Almeida ◽  
Mohammad-Ali Shahbazi ◽  
Ermei Mäkilä ◽  
Martti Kaasalainen ◽  
Jarno Salonen ◽  
...  

Synthesis of amine-modified hyaluronic acid porous silicon nanoparticles resulted in a suitable and promising nanodelivery system for the targeting of CD44-overexpressing tumors.

2015 ◽  
Vol 7 (41) ◽  
pp. 23197-23204 ◽  
Author(s):  
Alexandra Correia ◽  
Mohammad-Ali Shahbazi ◽  
Ermei Mäkilä ◽  
Sérgio Almeida ◽  
Jarno Salonen ◽  
...  

Pharmaceutics ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 686 ◽  
Author(s):  
Dave Lumen ◽  
Simo Näkki ◽  
Surachet Imlimthan ◽  
Elisavet Lambidis ◽  
Mirkka Sarparanta ◽  
...  

Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous silicon (DPEG-TOPSi) NPs and investigation of influence of the PEGylation on blood circulation time of TOPSi NPs. Trans-cyclooctene conjugated DPEG-TOPSi NPs were radiolabeled through a click reaction with [111In]In-DOTA-PEG4-tetrazine (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the particle behavior was evaluated in vivo in Balb/c mice bearing 4T1 murine breast cancer allografts. The dual-PEGylation significantly prolonged circulation of [111In]In-DPEG-TOPSi particles when compared to non-PEGylated control particles, yielding 10.8 ± 1.7% of the injected activity/g in blood at 15 min for [111In]In-DPEG-TOPSi NPs. The improved circulation time will be beneficial for the accumulation of targeted DPEG-TOPSi to tumors.


2021 ◽  
Author(s):  
Byungji Kim ◽  
Qinglin Yang ◽  
Leslie W. Chan ◽  
Sangeeta N. Bhatia ◽  
Erkki Ruoslahti ◽  
...  

RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.


2018 ◽  
Vol 30 (35) ◽  
pp. 1802878 ◽  
Author(s):  
Yusung Jin ◽  
Dokyoung Kim ◽  
Hajung Roh ◽  
Sojeong Kim ◽  
Sazid Hussain ◽  
...  

2020 ◽  
Vol 1439 ◽  
pp. 012035
Author(s):  
V K Tishchenko ◽  
V. M. Petriev ◽  
A A Mikhailovskaya ◽  
O A Smoryzanova ◽  
A V Kabashin ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Sana Sheykhzadeh ◽  
Meihua Luo ◽  
Bo Peng ◽  
Jacinta White ◽  
Youssef Abdalla ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document